Holland & Knight Health Dose provides a comprehensive weekly update on legislative and regulatory developments in Washington, D.C. that impact the health sector. This newsletter keeps stakeholders informed on important issues shaping the healthcare landscape.
This week’s edition covers a range of topics including Senator Cassidy’s questioning of FDA oversight of clinical decision support software, Buchanan’s call for MedPAC to reconsider their approach to digital health tools, and the rekindling of the conversation on surprise billing.
Other highlights include discussions on potential reforms in the areas of PBM, 340B, and Medicare PFS, as well as extensions for telehealth flexibility. Additionally, retirements in the healthcare sector, a new center for clinical trial innovation announced by CDER, and updates from the CBO, CMS, FTC, and ONC are also featured in this week’s Health Dose.
For more information and the full Health Dose newsletter, please click on the link provided. Stay informed and up-to-date on the latest developments in health policy and regulation.